Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1627
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18569352 | IL4I1 INHIBITORS AND METHODS OF USE | Non-Final OA | Merck Sharp & Dohme LLC |
| 18700110 | 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Non-Final OA | Vanderbilt University |
| 18708426 | COMPOSITION FOR INHIBITING HISTAMINE-N-METHYLTRANSFERASE | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 18533710 | SOLID FORMS OF (3R)-N-[2-CYANO-4-FLUORO-3-(3-METHYL-4-OXO-QUINAZOLIN-6-YL)OXY-PHENYL]-3-FLUORO-PYRROLIDINE-1-SULFONAMIDE | Non-Final OA | Hoffmann-La Roche Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy